ACE2 and COVID-19: In the case of COVID-19, it has been proposed that SARS-CoV-2 may primarily affect tissues and organs expressing angiotensin-converting enzyme (ACE2), such as the lung, liver, heart, and gastrointestinal tract [9, 15, 16].